Results 221 to 230 of about 24,071 (243)

Aflibercept

Reactions Weekly, 2015
openaire   +2 more sources

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR

Advances in Therapy, 2020
Kanji Takahashi, Annabelle A Okada
exaly  

Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review

International Journal of Molecular Sciences, 2022
Sławomir Liberski, Małgorzata Wichrowska, Jaroslaw Kociecki   +2 more
exaly  

Aflibercept

Reactions Weekly, 2016
openaire   +2 more sources

Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

Ophthalmology, 2014
Ursula M Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik   +2 more
exaly  

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Journal of Clinical Oncology, 2012
Josep Tabernero Caturla, Hans Prenen
exaly  

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

New England Journal of Medicine, 2015
Lee M Jampol, Michael J Elman, Jennifer K Sun   +2 more
exaly  

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Lancet Oncology, The, 2013
Vladimir Borisovich Matveev, Tony Elliott, Daniel P Petrylak   +2 more
exaly  

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology, 2016
Jean-François Korobelnik, Ursula M Schmidt-Erfurth, Edoardo Midena   +2 more
exaly  

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

British Journal of Ophthalmology, 2014
Mauricio Maia
exaly